These results suggest that SO is more efficient in activating the Keap1-Nrf2 signaling pathway compared to treatment with AVA, which confirms that oat phenolic compounds together with β-glucans may be acting synergistically, thus offering greater protection for cancer prevention and treatment [65,83]. The gene discussed is KEAP1; the disease is cancer.